Cannabidiol Market Size, Share & Trends Analysis Report By Source Type (Hemp, Marijuana), By Sales Type (B2B, B2C), By End-use (Medical, Personal Use), By Region, And Segment Forecasts, 2024 - 2030
- Report ID: GVR-3-68038-122-1
- Number of Pages: 150
- Format: Electronic (PDF)
- Historical Range: 2018 - 2022
- Industry: Healthcare
Market Segmentation
- Cannabidiol Source Type Outlook (Revenue, USD Million, 2018 - 2030)
- Hemp
- Marijuana
- Cannabidiol Sales Type Outlook (Revenue, USD Million, 2018 - 2030)
- B2B
- By End-use
- Pharmaceuticals
- Wellness
- Food & Beverages
- Personal Care & Cosmetics
- Nutraceuticals
- Others
- By End-use
- B2C
- By Sales Channel
- Hospital Pharmacies
- Online
- Retail Stores
- By End-use
- Medical
- Chronic Pain
- Mental Disorders
- Cancer
- Others
- Personal Use
- Medical
- By Sales Channel
- B2B
- End-use Outlook (Revenue, USD Million, 2018 - 2030)
- Medical
- Chronic Pain
- Mental Disorders
- Cancer
- Others
- Personal Use
- Pharmaceuticals
- Wellness
- Food & Beverages
- Personal Care & Cosmetics
- Nutraceuticals
- Others
- Medical
- Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
- North America Cannabidiol Source Type Outlook (Revenue, USD Million, 2018 - 2030)
- Hemp
- Marijuana
- North America Cannabidiol Sales Type Outlook (Revenue, USD Million, 2018 - 2030)
- B2B
- By End-use
- Pharmaceuticals
- Wellness
- Food & Beverages
- Personal Care & Cosmetics
- Nutraceuticals
- Others
- By End-use
- B2C
- By Sales Channel
- Hospital Pharmacies
- Online
- Retail Stores
- By End-use
- Medical
- Chronic Pain
- Mental Disorders
- Cancer
- Others
- Personal Use
- Medical
- By Sales Channel
- North America Cannabidiol End-use Outlook (Revenue, USD Million, 2018 - 2030)
- Medical
- Chronic Pain
- Mental Disorders
- Cancer
- Others
- Personal Use
- Pharmaceuticals
- Wellness
- Food & Beverages
- Personal Care & Cosmetics
- Nutraceuticals
- Others
- Medical
- B2B
- U.S.
- U.S. Cannabidiol Source Type Outlook (Revenue, USD Million, 2018 - 2030)
- Hemp
- Marijuana
- U.S. Cannabidiol Sales Type Outlook (Revenue, USD Million, 2018 - 2030)
- B2B
- By End-use
- Pharmaceuticals
- Wellness
- Food & Beverages
- Personal Care & Cosmetics
- Nutraceuticals
- Others
- By End-use
- B2C
- By Sales Channel
- Hospital Pharmacies
- Online
- Retail Stores
- By End-use
- Medical
- Chronic Pain
- Mental Disorders
- Cancer
- Others
- Personal Use
- Medical
- By Sales Channel
- B2B
- U.S. Cannabidiol End-use Outlook (Revenue, USD Million, 2018 - 2030)
- Medical
- Chronic Pain
- Mental Disorders
- Cancer
- Others
- Personal Use
- Pharmaceuticals
- Wellness
- Food & Beverages
- Personal Care & Cosmetics
- Nutraceuticals
- Others
- Medical
- U.S. Cannabidiol Source Type Outlook (Revenue, USD Million, 2018 - 2030)
- Canada
- Canada Cannabidiol Source Type Outlook (Revenue, USD Million, 2018 - 2030)
- Hemp
- Marijuana
- Canada Cannabidiol Sales Type Outlook (Revenue, USD Million, 2018 - 2030)
- B2B
- By End-use
- Pharmaceuticals
- Wellness
- Food & Beverages
- Personal Care & Cosmetics
- Nutraceuticals
- Others
- By End-use
- B2C
- By Sales Channel
- Hospital Pharmacies
- Online
- Retail Stores
- By End-use
- Medical
- Chronic Pain
- Mental Disorders
- Cancer
- Others
- Personal Use
- Medical
- By Sales Channel
- B2B
- Canada Cannabidiol End-use Outlook (Revenue, USD Million, 2018 - 2030)
- Medical
- Chronic Pain
- Mental Disorders
- Cancer
- Others
- Personal Use
- Pharmaceuticals
- Wellness
- Food & Beverages
- Personal Care & Cosmetics
- Nutraceuticals
- Others
- Medical
- Canada Cannabidiol Source Type Outlook (Revenue, USD Million, 2018 - 2030)
- North America Cannabidiol Source Type Outlook (Revenue, USD Million, 2018 - 2030)
- Europe
- Europe Cannabidiol Source Type Outlook (Revenue, USD Million, 2018 - 2030)
- Hemp
- Marijuana
- Europe Cannabidiol Sales Type Outlook (Revenue, USD Million, 2018 - 2030)
- B2B
- By End-use
- Pharmaceuticals
- Wellness
- Food & Beverages
- Personal Care & Cosmetics
- Nutraceuticals
- Others
- By End-use
- B2C
- By Sales Channel
- Hospital Pharmacies
- Online
- Retail Stores
- By End-use
- Medical
- Chronic Pain
- Mental Disorders
- Cancer
- Others
- Personal Use
- Medical
- By Sales Channel
- B2B
- Europe Cannabidiol End-use Outlook (Revenue, USD Million, 2018 - 2030)
- Medical
- Chronic Pain
- Mental Disorders
- Cancer
- Others
- Personal Use
- Pharmaceuticals
- Wellness
- Food & Beverages
- Personal Care & Cosmetics
- Nutraceuticals
- Others
- Medical
- U.K.
- U.K. Cannabidiol Source Type Outlook (Revenue, USD Million, 2018 - 2030)
- Hemp
- Marijuana
- U.K. Cannabidiol Sales Type Outlook (Revenue, USD Million, 2018 - 2030)
- B2B
- By End-use
- Pharmaceuticals
- Wellness
- Food & Beverages
- Personal Care & Cosmetics
- Nutraceuticals
- Others
- By End-use
- B2C
- By Sales Channel
- Hospital Pharmacies
- Online
- Retail Stores
- By End-use
- Medical
- Chronic Pain
- Mental Disorders
- Cancer
- Others
- Personal Use
- Medical
- By Sales Channel
- B2B
- U.K. Cannabidiol End-use Outlook (Revenue, USD Million, 2018 - 2030)
- Medical
- Chronic Pain
- Mental Disorders
- Cancer
- Others
- Personal Use
- Pharmaceuticals
- Wellness
- Food & Beverages
- Personal Care & Cosmetics
- Nutraceuticals
- Others
- Medical
- U.K. Cannabidiol Source Type Outlook (Revenue, USD Million, 2018 - 2030)
- Germany
- Germany Cannabidiol Source Type Outlook (Revenue, USD Million, 2018 - 2030)
- Hemp
- Marijuana
- Germany Cannabidiol Sales Type Outlook (Revenue, USD Million, 2018 - 2030)
- B2B
- By End-use
- Pharmaceuticals
- Wellness
- Food & Beverages
- Personal Care & Cosmetics
- Nutraceuticals
- Others
- By End-use
- B2C
- By Sales Channel
- Hospital Pharmacies
- Online
- Retail Stores
- By End-use
- Medical
- Chronic Pain
- Mental Disorders
- Cancer
- Others
- Personal Use
- Medical
- By Sales Channel
- B2B
- Germany Cannabidiol End-use Outlook (Revenue, USD Million, 2018 - 2030)
- Medical
- Chronic Pain
- Mental Disorders
- Cancer
- Others
- Personal Use
- Pharmaceuticals
- Wellness
- Food & Beverages
- Personal Care & Cosmetics
- Nutraceuticals
- Others
- Medical
- Germany Cannabidiol Source Type Outlook (Revenue, USD Million, 2018 - 2030)
- Netherlands
- Netherlands Cannabidiol Source Type Outlook (Revenue, USD Million, 2018 - 2030)
- Hemp
- Marijuana
- Netherlands Cannabidiol Sales Type Outlook (Revenue, USD Million, 2018 - 2030)
- B2B
- By End-use
- Pharmaceuticals
- Wellness
- Food & Beverages
- Personal Care & Cosmetics
- Nutraceuticals
- Others
- By End-use
- B2C
- By Sales Channel
- Hospital Pharmacies
- Online
- Retail Stores
- By End-use
- Medical
- Chronic Pain
- Mental Disorders
- Cancer
- Others
- Personal Use
- Medical
- By Sales Channel
- B2B
- Netherlands Cannabidiol End-use Outlook (Revenue, USD Million, 2018 - 2030)
- Medical
- Chronic Pain
- Mental Disorders
- Cancer
- Others
- Personal Use
- Pharmaceuticals
- Wellness
- Food & Beverages
- Personal Care & Cosmetics
- Nutraceuticals
- Others
- Medical
- Netherlands Cannabidiol Source Type Outlook (Revenue, USD Million, 2018 - 2030)
- Switzerland
- Switzerland Cannabidiol Source Type Outlook (Revenue, USD Million, 2018 - 2030)
- Hemp
- Marijuana
- Switzerland Cannabidiol Sales Type Outlook (Revenue, USD Million, 2018 - 2030)
- B2B
- By End-use
- Pharmaceuticals
- Wellness
- Food & Beverages
- Personal Care & Cosmetics
- Nutraceuticals
- Others
- By End-use
- B2C
- By Sales Channel
- Hospital Pharmacies
- Online
- Retail Stores
- By End-use
- Medical
- Chronic Pain
- Mental Disorders
- Cancer
- Others
- Personal Use
- Medical
- By Sales Channel
- B2B
- Switzerland Cannabidiol End-use Outlook (Revenue, USD Million, 2018 - 2030)
- Medical
- Chronic Pain
- Mental Disorders
- Cancer
- Others
- Personal Use
- Pharmaceuticals
- Wellness
- Food & Beverages
- Personal Care & Cosmetics
- Nutraceuticals
- Others
- Medical
- Switzerland Cannabidiol Source Type Outlook (Revenue, USD Million, 2018 - 2030)
- Italy
- Italy Cannabidiol Source Type Outlook (Revenue, USD Million, 2018 - 2030)
- Hemp
- Marijuana
- Italy Cannabidiol Sales Type Outlook (Revenue, USD Million, 2018 - 2030)
- B2B
- By End-use
- Pharmaceuticals
- Wellness
- Food & Beverages
- Personal Care & Cosmetics
- Nutraceuticals
- Others
- By End-use
- B2C
- By Sales Channel
- Hospital Pharmacies
- Online
- Retail Stores
- By End-use
- Medical
- Chronic Pain
- Mental Disorders
- Cancer
- Others
- Personal Use
- Medical
- By Sales Channel
- B2B
- Italy Cannabidiol End-use Outlook (Revenue, USD Million, 2018 - 2030)
- Medical
- Chronic Pain
- Mental Disorders
- Cancer
- Others
- Personal Use
- Pharmaceuticals
- Wellness
- Food & Beverages
- Personal Care & Cosmetics
- Nutraceuticals
- Others
- Medical
- Italy Cannabidiol Source Type Outlook (Revenue, USD Million, 2018 - 2030)
- France
- France Cannabidiol Source Type Outlook (Revenue, USD Million, 2018 - 2030)
- Hemp
- Marijuana
- France Cannabidiol Sales Type Outlook (Revenue, USD Million, 2018 - 2030)
- B2B
- By End-use
- Pharmaceuticals
- Wellness
- Food & Beverages
- Personal Care & Cosmetics
- Nutraceuticals
- Others
- By End-use
- B2C
- By Sales Channel
- Hospital Pharmacies
- Online
- Retail Stores
- By End-use
- Medical
- Chronic Pain
- Mental Disorders
- Cancer
- Others
- Personal Use
- Medical
- By Sales Channel
- B2B
- France Cannabidiol End-use Outlook (Revenue, USD Million, 2018 - 2030)
- Medical
- Chronic Pain
- Mental Disorders
- Cancer
- Others
- Personal Use
- Pharmaceuticals
- Wellness
- Food & Beverages
- Personal Care & Cosmetics
- Nutraceuticals
- Others
- Medical
- France Cannabidiol Source Type Outlook (Revenue, USD Million, 2018 - 2030)
- Poland
- Poland Cannabidiol Source Type Outlook (Revenue, USD Million, 2018 - 2030)
- Hemp
- Marijuana
- Poland Cannabidiol Sales Type Outlook (Revenue, USD Million, 2018 - 2030)
- B2B
- By End-use
- Pharmaceuticals
- Wellness
- Food & Beverages
- Personal Care & Cosmetics
- Nutraceuticals
- Others
- By End-use
- B2C
- By Sales Channel
- Hospital Pharmacies
- Online
- Retail Stores
- By End-use
- Medical
- Chronic Pain
- Mental Disorders
- Cancer
- Others
- Personal Use
- Medical
- By Sales Channel
- B2B
- Poland Cannabidiol End-use Outlook (Revenue, USD Million, 2018 - 2030)
- Medical
- Chronic Pain
- Mental Disorders
- Cancer
- Others
- Personal Use
- Pharmaceuticals
- Wellness
- Food & Beverages
- Personal Care & Cosmetics
- Nutraceuticals
- Others
- Medical
- Poland Cannabidiol Source Type Outlook (Revenue, USD Million, 2018 - 2030)
- Czech Republic
- Czech Republic Cannabidiol Source Type Outlook (Revenue, USD Million, 2018 - 2030)
- Hemp
- Marijuana
- Czech Republic Cannabidiol Sales Type Outlook (Revenue, USD Million, 2018 - 2030)
- B2B
- By End-use
- Pharmaceuticals
- Wellness
- Food & Beverages
- Personal Care & Cosmetics
- Nutraceuticals
- Others
- By End-use
- B2C
- By Sales Channel
- Hospital Pharmacies
- Online
- Retail Stores
- By End-use
- Medical
- Chronic Pain
- Mental Disorders
- Cancer
- Others
- Personal Use
- Medical
- By Sales Channel
- B2B
- Czech Republic Cannabidiol End-use Outlook (Revenue, USD Million, 2018 - 2030)
- Medical
- Chronic Pain
- Mental Disorders
- Cancer
- Others
- Personal Use
- Pharmaceuticals
- Wellness
- Food & Beverages
- Personal Care & Cosmetics
- Nutraceuticals
- Others
- Medical
- Czech Republic Cannabidiol Source Type Outlook (Revenue, USD Million, 2018 - 2030)
- Croatia
- Croatia Cannabidiol Source Type Outlook (Revenue, USD Million, 2018 - 2030)
- Hemp
- Marijuana
- Croatia Cannabidiol Sales Type Outlook (Revenue, USD Million, 2018 - 2030)
- B2B
- By End-use
- Pharmaceuticals
- Wellness
- Food & Beverages
- Personal Care & Cosmetics
- Nutraceuticals
- Others
- By End-use
- B2C
- By Sales Channel
- Hospital Pharmacies
- Online
- Retail Stores
- By End-use
- Medical
- Chronic Pain
- Mental Disorders
- Cancer
- Others
- Personal Use
- Medical
- By Sales Channel
- B2B
- Croatia Cannabidiol End-use Outlook (Revenue, USD Million, 2018 - 2030)
- Medical
- Chronic Pain
- Mental Disorders
- Cancer
- Others
- Personal Use
- Pharmaceuticals
- Wellness
- Food & Beverages
- Personal Care & Cosmetics
- Nutraceuticals
- Others
- Medical
- Croatia Cannabidiol Source Type Outlook (Revenue, USD Million, 2018 - 2030)
- Europe Cannabidiol Source Type Outlook (Revenue, USD Million, 2018 - 2030)
- Asia Pacific
- Asia Pacific Cannabidiol Source Type Outlook (Revenue, USD Million, 2018 - 2030)
- Hemp
- Marijuana
- Asia Pacific Cannabidiol Sales Type Outlook (Revenue, USD Million, 2018 - 2030)
- B2B
- By End-use
- Pharmaceuticals
- Wellness
- Food & Beverages
- Personal Care & Cosmetics
- Nutraceuticals
- Others
- By End-use
- B2C
- By Sales Channel
- Hospital Pharmacies
- Online
- Retail Stores
- By End-use
- Medical
- Chronic Pain
- Mental Disorders
- Cancer
- Others
- Personal Use
- Medical
- By Sales Channel
- B2B
- Asia Pacific Cannabidiol End-use Outlook (Revenue, USD Million, 2018 - 2030)
- Medical
- Chronic Pain
- Mental Disorders
- Cancer
- Others
- Personal Use
- Pharmaceuticals
- Wellness
- Food & Beverages
- Personal Care & Cosmetics
- Nutraceuticals
- Others
- Medical
- China
- China Cannabidiol Source Type Outlook (Revenue, USD Million, 2018 - 2030)
- Hemp
- Marijuana
- China Cannabidiol Sales Type Outlook (Revenue, USD Million, 2018 - 2030)
- B2B
- By End-use
- Pharmaceuticals
- Wellness
- Food & Beverages
- Personal Care & Cosmetics
- Nutraceuticals
- Others
- By End-use
- B2C
- By Sales Channel
- Hospital Pharmacies
- Online
- Retail Stores
- By End-use
- Medical
- Chronic Pain
- Mental Disorders
- Cancer
- Others
- Personal Use
- Medical
- By Sales Channel
- B2B
- China Cannabidiol End-use Outlook (Revenue, USD Million, 2018 - 2030)
- Medical
- Chronic Pain
- Mental Disorders
- Cancer
- Others
- Personal Use
- Pharmaceuticals
- Wellness
- Food & Beverages
- Personal Care & Cosmetics
- Nutraceuticals
- Others
- Medical
- China Cannabidiol Source Type Outlook (Revenue, USD Million, 2018 - 2030)
- India
- India Cannabidiol Source Type Outlook (Revenue, USD Million, 2018 - 2030)
- Hemp
- Marijuana
- India Cannabidiol Sales Type Outlook (Revenue, USD Million, 2018 - 2030)
- B2B
- By End-use
- Pharmaceuticals
- Wellness
- Food & Beverages
- Personal Care & Cosmetics
- Nutraceuticals
- Others
- By End-use
- B2C
- By Sales Channel
- Hospital Pharmacies
- Online
- Retail Stores
- By End-use
- Medical
- Chronic Pain
- Mental Disorders
- Cancer
- Others
- Personal Use
- Medical
- By Sales Channel
- B2B
- India Cannabidiol End-use Outlook (Revenue, USD Million, 2018 - 2030)
- Medical
- Chronic Pain
- Mental Disorders
- Cancer
- Others
- Personal Use
- Pharmaceuticals
- Wellness
- Food & Beverages
- Personal Care & Cosmetics
- Nutraceuticals
- Others
- Medical
- India Cannabidiol Source Type Outlook (Revenue, USD Million, 2018 - 2030)
- South Korea
- South Korea Cannabidiol Source Type Outlook (Revenue, USD Million, 2018 - 2030)
- Hemp
- Marijuana
- South Korea Cannabidiol Sales Type Outlook (Revenue, USD Million, 2018 - 2030)
- B2B
- By End-use
- Pharmaceuticals
- Wellness
- Food & Beverages
- Personal Care & Cosmetics
- Nutraceuticals
- Others
- By End-use
- B2C
- By Sales Channel
- Hospital Pharmacies
- Online
- Retail Stores
- By End-use
- Medical
- Chronic Pain
- Mental Disorders
- Cancer
- Others
- Personal Use
- Medical
- By Sales Channel
- B2B
- South Korea Cannabidiol End-use Outlook (Revenue, USD Million, 2018 - 2030)
- Medical
- Chronic Pain
- Mental Disorders
- Cancer
- Others
- Personal Use
- Pharmaceuticals
- Wellness
- Food & Beverages
- Personal Care & Cosmetics
- Nutraceuticals
- Others
- Medical
- South Korea Cannabidiol Source Type Outlook (Revenue, USD Million, 2018 - 2030)
- Japan
- Japan Cannabidiol Source Type Outlook (Revenue, USD Million, 2018 - 2030)
- Hemp
- Marijuana
- Japan Cannabidiol Sales Type Outlook (Revenue, USD Million, 2018 - 2030)
- B2B
- By End-use
- Pharmaceuticals
- Wellness
- Food & Beverages
- Personal Care & Cosmetics
- Nutraceuticals
- Others
- By End-use
- B2C
- By Sales Channel
- Hospital Pharmacies
- Online
- Retail Stores
- By End-use
- Medical
- Chronic Pain
- Mental Disorders
- Cancer
- Others
- Personal Use
- Medical
- By Sales Channel
- B2B
- Japan Cannabidiol End-use Outlook (Revenue, USD Million, 2018 - 2030)
- Medical
- Chronic Pain
- Mental Disorders
- Cancer
- Others
- Personal Use
- Pharmaceuticals
- Wellness
- Food & Beverages
- Personal Care & Cosmetics
- Nutraceuticals
- Others
- Medical
- Japan Cannabidiol Source Type Outlook (Revenue, USD Million, 2018 - 2030)
- New Zealand
- New Zealand Cannabidiol Source Type Outlook (Revenue, USD Million, 2018 - 2030)
- Hemp
- Marijuana
- New Zealand Cannabidiol Sales Type Outlook (Revenue, USD Million, 2018 - 2030)
- B2B
- By End-use
- Pharmaceuticals
- Wellness
- Food & Beverages
- Personal Care & Cosmetics
- Nutraceuticals
- Others
- By End-use
- B2C
- By Sales Channel
- Hospital Pharmacies
- Online
- Retail Stores
- By End-use
- Medical
- Chronic Pain
- Mental Disorders
- Cancer
- Others
- Personal Use
- Medical
- By Sales Channel
- B2B
- New Zealand Cannabidiol End-use Outlook (Revenue, USD Million, 2018 - 2030)
- Medical
- Chronic Pain
- Mental Disorders
- Cancer
- Others
- Personal Use
- Pharmaceuticals
- Wellness
- Food & Beverages
- Personal Care & Cosmetics
- Nutraceuticals
- Others
- Medical
- New Zealand Cannabidiol Source Type Outlook (Revenue, USD Million, 2018 - 2030)
- Australia
- Australia Cannabidiol Source Type Outlook (Revenue, USD Million, 2018 - 2030)
- Hemp
- Marijuana
- Australia Cannabidiol Sales Type Outlook (Revenue, USD Million, 2018 - 2030)
- B2B
- By End-use
- Pharmaceuticals
- Wellness
- Food & Beverages
- Personal Care & Cosmetics
- Nutraceuticals
- Others
- By End-use
- B2C
- By Sales Channel
- Hospital Pharmacies
- Online
- Retail Stores
- By End-use
- Medical
- Chronic Pain
- Mental Disorders
- Cancer
- Others
- Personal Use
- Medical
- By Sales Channel
- B2B
- Australia Cannabidiol End-use Outlook (Revenue, USD Million, 2018 - 2030)
- Medical
- Chronic Pain
- Mental Disorders
- Cancer
- Others
- Personal Use
- Pharmaceuticals
- Wellness
- Food & Beverages
- Personal Care & Cosmetics
- Nutraceuticals
- Others
- Medical
- Australia Cannabidiol Source Type Outlook (Revenue, USD Million, 2018 - 2030)
- Asia Pacific Cannabidiol Source Type Outlook (Revenue, USD Million, 2018 - 2030)
- Latin America
- Latin America Cannabidiol Source Type Outlook (Revenue, USD Million, 2018 - 2030)
- Hemp
- Marijuana
- Latin America Cannabidiol Sales Type Outlook (Revenue, USD Million, 2018 - 2030)
- B2B
- By End-use
- Pharmaceuticals
- Wellness
- Food & Beverages
- Personal Care & Cosmetics
- Nutraceuticals
- Others
- By End-use
- B2C
- By Sales Channel
- Hospital Pharmacies
- Online
- Retail Stores
- By End-use
- Medical
- Chronic Pain
- Mental Disorders
- Cancer
- Others
- Personal Use
- Medical
- By Sales Channel
- B2B
- Latin America Cannabidiol End-use Outlook (Revenue, USD Million, 2018 - 2030)
- Medical
- Chronic Pain
- Mental Disorders
- Cancer
- Others
- Personal Use
- Pharmaceuticals
- Wellness
- Food & Beverages
- Personal Care & Cosmetics
- Nutraceuticals
- Others
- Medical
- Argentina
- Argentina Cannabidiol Source Type Outlook (Revenue, USD Million, 2018 - 2030)
- Hemp
- Marijuana
- Argentina Cannabidiol Sales Type Outlook (Revenue, USD Million, 2018 - 2030)
- B2B
- By End-use
- Pharmaceuticals
- Wellness
- Food & Beverages
- Personal Care & Cosmetics
- Nutraceuticals
- Others
- By End-use
- B2C
- By Sales Channel
- Hospital Pharmacies
- Online
- Retail Stores
- By End-use
- Medical
- Chronic Pain
- Mental Disorders
- Cancer
- Others
- Personal Use
- Medical
- By Sales Channel
- B2B
- Argentina Cannabidiol End-use Outlook (Revenue, USD Million, 2018 - 2030)
- Medical
- Chronic Pain
- Mental Disorders
- Cancer
- Others
- Personal Use
- Pharmaceuticals
- Wellness
- Food & Beverages
- Personal Care & Cosmetics
- Nutraceuticals
- Others
- Medical
- Argentina Cannabidiol Source Type Outlook (Revenue, USD Million, 2018 - 2030)
- Brazil
- Brazil Cannabidiol Source Type Outlook (Revenue, USD Million, 2018 - 2030)
- Hemp
- Marijuana
- Brazil Cannabidiol Sales Type Outlook (Revenue, USD Million, 2018 - 2030)
- B2B
- By End-use
- Pharmaceuticals
- Wellness
- Food & Beverages
- Personal Care & Cosmetics
- Nutraceuticals
- Others
- By End-use
- B2C
- By Sales Channel
- Hospital Pharmacies
- Online
- Retail Stores
- By End-use
- Medical
- Chronic Pain
- Mental Disorders
- Cancer
- Others
- Personal Use
- Medical
- By Sales Channel
- B2B
- Brazil Cannabidiol End-use Outlook (Revenue, USD Million, 2018 - 2030)
- Medical
- Chronic Pain
- Mental Disorders
- Cancer
- Others
- Personal Use
- Pharmaceuticals
- Wellness
- Food & Beverages
- Personal Care & Cosmetics
- Nutraceuticals
- Others
- Medical
- Brazil Cannabidiol Source Type Outlook (Revenue, USD Million, 2018 - 2030)
- Mexico
- Mexico Cannabidiol Source Type Outlook (Revenue, USD Million, 2018 - 2030)
- Hemp
- Marijuana
- Mexico Cannabidiol Sales Type Outlook (Revenue, USD Million, 2018 - 2030)
- B2B
- By End-use
- Pharmaceuticals
- Wellness
- Food & Beverages
- Personal Care & Cosmetics
- Nutraceuticals
- Others
- By End-use
- B2C
- By Sales Channel
- Hospital Pharmacies
- Online
- Retail Stores
- By End-use
- Medical
- Chronic Pain
- Mental Disorders
- Cancer
- Others
- Personal Use
- Medical
- By Sales Channel
- B2B
- Mexico Cannabidiol End-use Outlook (Revenue, USD Million, 2018 - 2030)
- Medical
- Chronic Pain
- Mental Disorders
- Cancer
- Others
- Personal Use
- Pharmaceuticals
- Wellness
- Food & Beverages
- Personal Care & Cosmetics
- Nutraceuticals
- Others
- Medical
- Mexico Cannabidiol Source Type Outlook (Revenue, USD Million, 2018 - 2030)
- Colombia
- Colombia Cannabidiol Source Type Outlook (Revenue, USD Million, 2018 - 2030)
- Hemp
- Marijuana
- Colombia Cannabidiol Sales Type Outlook (Revenue, USD Million, 2018 - 2030)
- B2B
- By End-use
- Pharmaceuticals
- Wellness
- Food & Beverages
- Personal Care & Cosmetics
- Nutraceuticals
- Others
- By End-use
- B2C
- By Sales Channel
- Hospital Pharmacies
- Online
- Retail Stores
- By End-use
- Medical
- Chronic Pain
- Mental Disorders
- Cancer
- Others
- Personal Use
- Medical
- By Sales Channel
- B2B
- Colombia Cannabidiol End-use Outlook (Revenue, USD Million, 2018 - 2030)
- Medical
- Chronic Pain
- Mental Disorders
- Cancer
- Others
- Personal Use
- Pharmaceuticals
- Wellness
- Food & Beverages
- Personal Care & Cosmetics
- Nutraceuticals
- Others
- Medical
- Colombia Cannabidiol Source Type Outlook (Revenue, USD Million, 2018 - 2030)
- Uruguay
- Uruguay Cannabidiol Source Type Outlook (Revenue, USD Million, 2018 - 2030)
- Hemp
- Marijuana
- Uruguay Cannabidiol Sales Type Outlook (Revenue, USD Million, 2018 - 2030)
- B2B
- By End-use
- Pharmaceuticals
- Wellness
- Food & Beverages
- Personal Care & Cosmetics
- Nutraceuticals
- Others
- By End-use
- B2C
- By Sales Channel
- Hospital Pharmacies
- Online
- Retail Stores
- By End-use
- Medical
- Chronic Pain
- Mental Disorders
- Cancer
- Others
- Personal Use
- Medical
- By Sales Channel
- B2B
- Uruguay Cannabidiol End-use Outlook (Revenue, USD Million, 2018 - 2030)
- Medical
- Chronic Pain
- Mental Disorders
- Cancer
- Others
- Personal Use
- Pharmaceuticals
- Wellness
- Food & Beverages
- Personal Care & Cosmetics
- Nutraceuticals
- Others
- Medical
- Uruguay Cannabidiol Source Type Outlook (Revenue, USD Million, 2018 - 2030)
- Chile
- Chile Cannabidiol Source Type Outlook (Revenue, USD Million, 2018 - 2030)
- Hemp
- Marijuana
- Chile Cannabidiol Sales Type Outlook (Revenue, USD Million, 2018 - 2030)
- B2B
- By End-use
- Pharmaceuticals
- Wellness
- Food & Beverages
- Personal Care & Cosmetics
- Nutraceuticals
- Others
- By End-use
- B2C
- By Sales Channel
- Hospital Pharmacies
- Online
- Retail Stores
- By End-use
- Medical
- Chronic Pain
- Mental Disorders
- Cancer
- Others
- Personal Use
- Medical
- By Sales Channel
- B2B
- Chile Cannabidiol End-use Outlook (Revenue, USD Million, 2018 - 2030)
- Medical
- Chronic Pain
- Mental Disorders
- Cancer
- Others
- Personal Use
- Pharmaceuticals
- Wellness
- Food & Beverages
- Personal Care & Cosmetics
- Nutraceuticals
- Others
- Medical
- Chile Cannabidiol Source Type Outlook (Revenue, USD Million, 2018 - 2030)
- Latin America Cannabidiol Source Type Outlook (Revenue, USD Million, 2018 - 2030)
- Middle East & Africa (MEA)
- Middle East & Africa Cannabidiol Source Type Outlook (Revenue, USD Million, 2018 - 2030)
- Hemp
- Marijuana
- Middle East & Africa Cannabidiol Sales Type Outlook (Revenue, USD Million, 2018 - 2030)
- B2B
- By End-use
- Pharmaceuticals
- Wellness
- Food & Beverages
- Personal Care & Cosmetics
- Nutraceuticals
- Others
- By End-use
- B2C
- By Sales Channel
- Hospital Pharmacies
- Online
- Retail Stores
- By End-use
- Medical
- Chronic Pain
- Mental Disorders
- Cancer
- Others
- Personal Use
- Medical
- By Sales Channel
- B2B
- Middle East & Africa Cannabidiol End-use Outlook (Revenue, USD Million, 2018 - 2030)
- Medical
- Chronic Pain
- Mental Disorders
- Cancer
- Others
- Personal Use
- Pharmaceuticals
- Wellness
- Food & Beverages
- Personal Care & Cosmetics
- Nutraceuticals
- Others
- Medical
- Israel
- Israel Cannabidiol Source Type Outlook (Revenue, USD Million, 2018 - 2030)
- Hemp
- Marijuana
- Israel Cannabidiol Sales Type Outlook (Revenue, USD Million, 2018 - 2030)
- B2B
- By End-use
- Pharmaceuticals
- Wellness
- Food & Beverages
- Personal Care & Cosmetics
- Nutraceuticals
- Others
- By End-use
- B2C
- By Sales Channel
- Hospital Pharmacies
- Online
- Retail Stores
- By End-use
- Medical
- Chronic Pain
- Mental Disorders
- Cancer
- Others
- Personal Use
- Medical
- By Sales Channel
- B2B
- Israel Cannabidiol End-use Outlook (Revenue, USD Million, 2018 - 2030)
- Medical
- Chronic Pain
- Mental Disorders
- Cancer
- Others
- Personal Use
- Pharmaceuticals
- Wellness
- Food & Beverages
- Personal Care & Cosmetics
- Nutraceuticals
- Others
- Medical
- Israel Cannabidiol Source Type Outlook (Revenue, USD Million, 2018 - 2030)
- South Africa
- South Africa Cannabidiol Source Type Outlook (Revenue, USD Million, 2018 - 2030)
- Hemp
- Marijuana
- South Africa Cannabidiol Sales Type Outlook (Revenue, USD Million, 2018 - 2030)
- B2B
- By End-use
- Pharmaceuticals
- Wellness
- Food & Beverages
- Personal Care & Cosmetics
- Nutraceuticals
- Others
- By End-use
- B2C
- By Sales Channel
- Hospital Pharmacies
- Online
- Retail Stores
- By End-use
- Medical
- Chronic Pain
- Mental Disorders
- Cancer
- Others
- Personal Use
- Medical
- By Sales Channel
- B2B
- South Africa Cannabidiol End-use Outlook (Revenue, USD Million, 2018 - 2030)
- Medical
- Chronic Pain
- Mental Disorders
- Cancer
- Others
- Personal Use
- Pharmaceuticals
- Wellness
- Food & Beverages
- Personal Care & Cosmetics
- Nutraceuticals
- Others
- Medical
- South Africa Cannabidiol Source Type Outlook (Revenue, USD Million, 2018 - 2030)
- Middle East & Africa Cannabidiol Source Type Outlook (Revenue, USD Million, 2018 - 2030)
- North America
Cannabidiol Market Dynamics
Driver: Growing Legalization Of Cannabis-Based Cbd Products
In recent years, CBD has been legalized in several countries across the globe for industrial applications such as pharmaceuticals, personal care & cosmetics, and food & beverages, as it was found safe for human consumption when consumed in the prescribed quantity. There is a high demand for various CBD-infused products, such as beauty products, cannabis oil, beverages, gummies, capsules, etc. As per Federal law in the U.S., the production and distribution of hemp-based CBD have been legalized owing to its medicinal benefits. A few prominent states in the country, such as New Jersey, Delaware, Oklahoma, New Hampshire, Florida, Connecticut, and New Mexico, have legalized the use of cannabis only for medical purposes and not for recreational purposes. Such favorable regulations are anticipated to drive the CBD market over the forecast period. Growing marijuana has been legalized in most European countries, providing opportunities for startups dealing with marijuana-based products to explore the market. The European CBD market is characterized by favorable regulatory support for CBD.
Driver: Growing Adoption Of Cbd-Based Products For Treating Various Medical Conditions
Several scientific studies have confirmed the therapeutic properties of CBD, and CBD-based products are gaining wide recognition in the health and wellness sector. CBD is currently used by patients to treat various mental disorders, cancer, and arthritis, among others. CBD oil is a natural approach for treating anxiety and depression without creating any addiction. CBD has proven to be effective in reducing the number of seizures. Cancer patients undergoing chemotherapy and radiation treatments often suffer from nausea, vomiting, and postcancer pain. These adverse effects can be reduced by regular intake of CBD oil. These factors along with the associated medical benefits are likely to propel market growth over the forecast period.
Restraint: Stringent Government Regulations
In recent years, CBD has gained popularity across the globe and is used to treat a wide range of lifestyle diseases and medical conditions such as inflammation, pain, sleep disorders, epilepsy, schizophrenia, anorexia, symptoms of multiple sclerosis, and other conditions. In addition, CBD is in high demand for use in cosmetic products such as lotions, creams, and moisturizers, as well as in food items & beverages. However, there are several uncertainties pertaining to its safety, quality, and legality. In the European Union (EU), seeds for planting are only to be purchased from certified providers to ensure that the right variety of hemp is cultivated as hemp is a rich source of CBD. In addition, only outdoor agricultural fields are permitted in Europe. In the U.S., the cultivation of CBD is illegal in certain parts of the country even though CBD-infused products are available. These legal restriction and stringent government regulations can act as a hindrance to the market growth.
What Does This Report Include?
This section will provide insights into the contents included in this cannabidiol market report and help gain clarity on the structure of the report to assist readers in navigating smoothly.
Cannabidiol market qualitative analysis
-
Industry overview
-
Industry trends
-
Market drivers and restraints
-
Market size
-
Growth prospects
-
Porter’s analysis
-
PESTEL analysis
-
Key market opportunities prioritized
-
Competitive landscape
-
Company overview
-
Financial performance
-
Product benchmarking
-
Latest strategic developments
-
Cannabidiol market quantitative analysis
-
Market size, estimates, and forecast from 2018 to 2030
-
Market estimates and forecast for product segments up to 2030
-
Regional market size and forecast for product segments up to 2030
-
Market estimates and forecast for application segments up to 2030
-
Regional market size and forecast for application segments up to 2030
-
Company financial performance
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
ISO Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
